VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $281,194 | -93.5% | 30,010 | -83.1% | 0.00% | -88.9% |
| Q2 2023 | $4,359,005 | +5.4% | 177,701 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $4,135,103 | +43.1% | 177,701 | +55.6% | 0.01% | +28.6% |
| Q4 2022 | $2,890,149 | +40.3% | 114,190 | +6.9% | 0.01% | +40.0% |
| Q3 2022 | $2,060,000 | +17.8% | 106,840 | +55.5% | 0.01% | +25.0% |
| Q2 2022 | $1,749,000 | -40.1% | 68,689 | -39.5% | 0.00% | -33.3% |
| Q1 2022 | $2,919,000 | -36.9% | 113,509 | +2.7% | 0.01% | -33.3% |
| Q4 2021 | $4,629,000 | +458.4% | 110,569 | +358.3% | 0.01% | +350.0% |
| Q3 2020 | $829,000 | +265.2% | 24,128 | +334.7% | 0.00% | +100.0% |
| Q2 2020 | $227,000 | – | 5,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |